ICON Public (ICLR) Stock Forecast & Price Target

$202.25 +6.65 (+3.40%)

(As of 12:20 PM ET)

ICON Public - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
3

Buy
11

Based on 14 Wall Street analysts who have issued ratings for ICON Public in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, 10 have given a buy rating, and 1 has given a strong buy rating for ICLR.

Consensus Price Target

$292.45
44.60% Upside

According to the 14 analysts' twelve-month price targets for ICON Public, the average price target is $292.45. The highest price target for ICLR is $350.00, while the lowest price target for ICLR is $225.00. The average price target represents a forecasted upside of 44.60% from the current price of $202.25.

ICLR Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)	5 Buy rating(s)
Hold	3 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$292.45	$346.09	$352.56	$272.78
Forecasted Upside	44.60% Upside	19.90% Upside	10.06% Upside	0.63% Upside
Consensus Rating	Moderate Buy	Buy	Buy	Buy

Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

ICLR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ICON Public Stock vs. The Competition

Type	ICON Public	Medical Companies	S&P 500
Consensus Rating Score	2.86	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	54.86% Upside	28,009.67% Upside	9.98% Upside
News Sentiment Rating	Neutral News See Recent ICLR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/20/2024	Robert W. Baird 2 of 5 stars		Lower Target	Neutral ➝ Neutral	$249.00 ➝ $225.00	+15.03%
11/19/2024	Leerink Partners 1 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$270.00 ➝ $255.00	+34.38%
10/28/2024	Truist Financial 2 of 5 stars		Lower Target	Buy ➝ Buy	$363.00 ➝ $295.00	+33.81%
10/25/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$369.00 ➝ $285.00	+28.55%
10/25/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$330.00 ➝ $275.00	+24.47%
10/25/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$375.00 ➝ $280.00	+22.95%
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
10/25/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$370.00 ➝ $280.00	+22.95%
10/24/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
10/14/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$311.00	+5.43%
10/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$360.00 ➝ $350.00	+21.46%
9/18/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/31/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
4/4/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$346.00	+7.76%
12/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$300.00 ➝ $315.00	+15.61%
7/14/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$280.00 ➝ $300.00	+21.55%
5/1/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$245.00 ➝ $220.00	+14.17%
4/28/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$271.00 ➝ $263.00	+37.91%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:44 PM ET.

Should I Buy ICON Public Stock? ICLR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 8, 2024. Please send any questions or comments about these ICON Public pros and cons to contact@marketbeat.com.

ICON Public
Bull Case

Here are some ways that investors could benefit from investing in ICON Public Limited:

ICON Public Limited has a strong financial position with a debt-to-equity ratio of 0.36, indicating a healthy balance between debt and equity which can provide stability and growth opportunities.
The company's quick ratio and current ratio of 1.31 each suggest that ICON Public Limited has sufficient liquid assets to cover its short-term liabilities, reflecting good financial health.
Recent earnings results have been positive, with the company reporting $3.75 earnings per share for the quarter, surpassing analysts' estimates. This demonstrates strong financial performance and potential for growth.
Analysts have issued favorable ratings for ICON Public Limited, with a consensus of "Buy" and an average target price of $351.60, indicating confidence in the company's future prospects.
Despite a recent 2.2% trading dip, ICON Public Limited's stock price of $296.30 presents a potential buying opportunity for investors looking to enter at a lower price point.

ICON Public
Bear Case

Investors should be bearish about investing in ICON Public Limited for these reasons:

While the company has shown positive earnings, there is a slight revenue decrease of 4.1% on a year-over-year basis, which may indicate a potential challenge in maintaining revenue growth.

ICLR Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for ICON Public is $292.45, with a high forecast of $350.00 and a low forecast of $225.00.
: 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICON Public in the last year. There are currently 3 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ICLR shares.
: According to analysts, ICON Public's stock has a predicted upside of 44.60% based on their 12-month stock forecasts.
: Over the previous 90 days, ICON Public's stock had 2 downgrades and 1 upgrade by analysts.
: ICON Public has been rated by research analysts at Baird R W, Barclays, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Leerink Partnrs, Redburn Atlantic, Robert W. Baird, TD Cowen, The Goldman Sachs Group, and Truist Financial in the past 90 days.
: Analysts like ICON Public more than other "medical" companies. The consensus rating score for ICON Public is 2.86 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ICLR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

I've got news for you… (Ad)

Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week

watch this FREE briefing with me and expert trader Graham Lindman

This page (NASDAQ:ICLR) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ICON Public (ICLR) Stock Forecast & Price Target